A Two-cohort, Open-label, Fixed-sequence, Two-period, Two-treatment Pharmacokinetic Interaction Study of Repeated Oral Doses of Sotagliflozin on a Single Dose Cocktail of Metoprolol and Midazolam Used as Probe Substrates for CYP2D6 and CYP3A Activities, Respectively, in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Metoprolol (Primary) ; Midazolam (Primary) ; Sotagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Sanofi
- 17 Jan 2017 Status changed from recruiting to completed.
- 25 Oct 2016 New trial record
- 21 Oct 2016 Status changed from not yet recruiting to recruiting.